Fast delivery of flecainide via the pulmonary (bolus) or intravenous (rapid infusion) routes reduces atrial fibrillation conversion dose and minimizes negative inotropic burden
Year: 2020
Type: article
Source: European Heart Journal
Authors: L Belardinelli, B.D Nearing, R.L Verrier
Institutions: Beth Israel Deaconess Medical Center, Harvard University
Language: English
Subfield: Cardiology and Cardiovascular Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W3106773256
